Botswana vs Zambia: Cause of death, by non-communicable diseases, female
Botswana
34.9%
in 2021
Zambia
32.3%
in 2021
Botswana rank
175th
Zambia rank
178th
Cause of death, by non-communicable diseases, female over time
- Botswana
- Zambia
How they compare
Botswana currently reports 34.9% against 32.3% in Zambia, a difference of 2.6%.
That makes Botswana's figure about 1.1 times Zambia's.
Across all 6 years both countries report, Botswana has been ahead every year.
Botswana ranks 175th and Zambia ranks 178th of 185 countries.
Botswana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 14.1% | 0.6% | Botswana |
| 2010s | 40.6% | 26.1% | 14.5% | Botswana |
| 2020s | 40.1% | 31.8% | 8.4% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Botswana or Zambia?
- Botswana, at 34.9% against 32.3% in Zambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Botswana and Zambia?
- 2.6%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Zambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Botswana and Zambia rank globally for cause of death, by non-communicable diseases, female?
- Botswana ranks 175th and Zambia ranks 178th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.